如何解读肝炎病毒核酸定量检测结果.pptVIP

Architect HBsAg 检测 * * Architect HBsAg 检测 * Slide *. A number of baseline factors have a strong impact on SVR Swain, et al. investigated the complex relationships between body weight, other baseline factors, and treatment outcomes in patients treated with PEGASYS? plus COPEGUS? in two phase III studies.1,2 The SVR rate was significantly higher in patients in patients weighing ≤75.5 kg compared with 75.5 kg (67% vs 52%; p=0.00001). However, the SVR rate was also significantly higher in patients with genotype non-1 (p0.001 vs genotype 1), HCV RNA ≤1 million copies/mL (p0.001 vs 1 million copies